Fig. 1From: Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMTa cGVHD, b extensive cGVHD, and c GRFS by GVHD prophylaxis strategyBack to article page